港股创新药概念股持续反弹，歌礼制药涨近10%

Group 1 - The Hong Kong stock market's innovative drug concept stocks are experiencing a continuous rebound, with notable increases in share prices [1] - Specifically, Gilead Sciences-B has risen nearly 10%, while Zhaoyan New Drug has increased by over 8% [1] - Other companies such as Tigermed, Innovent Biologics, and CSPC Pharmaceutical Group have also seen their stock prices rise significantly [1]